Page 7 - Bluejay Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bluejay Diagnostics (NASDAQ:BJDX – Free Report) and IRadimed (NASDAQ:IRMD – Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Valuation & Earnings This table compares Bluejay Diagnostics and IRadimed’s […]

Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Free Report) saw a large increase in short interest in June. As of June 15th, there was short interest totalling 297,200 shares, an increase of 134.4% from the May 31st total of 126,800 shares. Approximately 2.6% of the company’s shares are short sold. Based on an average daily volume of […]

Biotricity (OTCMKTS:BTCY – Get Rating) and Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Profitability This table compares Biotricity and Bluejay Diagnostics’ net margins, […]

Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) – Research analysts at Zacks Small Cap issued their Q2 2023 earnings per share (EPS) estimates for Bluejay Diagnostics in a report issued on Wednesday, May 31st. Zacks Small Cap analyst J. Vandermosten forecasts that the company will post earnings of ($0.07) per share for the quarter. The […]

Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 29,600 shares, a growth of 15.2% from the April 30th total of 25,700 shares. Based on an average trading volume of 112,800 shares, the […]